Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

Michail Belyavskyi

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI profile picture
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox (-44 properties)
Infobox
Patent primary examiner of
‌
US Patent 7235371 Human osteoclast derived cathepsin
‌
US Patent 7235640 Isolated antibodies to a secretory membrane protein
‌
US Patent 7247474 Monoclonal antibody which specifically binds to but does not activate the CD8
‌
US Patent 7282222 Methods and compositions for directing cells to target organs
‌
US Patent 7285640 Antibody to stem cell factor
‌
US Patent 7288247 Antibodies for use in targeted and temporary treatment of humans and animals
‌
US Patent 7291332 Inflammatory mediator antagonists
‌
US Patent 7291451 Modulation of pericyte proliferation
‌
US Patent 7300760 Mammalian myeloid progenitor cell subsets
‌
US Patent 7303769 Method for purifying pluri-differentiated mesenchymal progenitor cells
‌
US Patent 7309585 121P1F1: a tissue specific protein highly expressed in various cancers
‌
US Patent 7312078 Methods of controlling proliferation and differentiation of stem and progenitor cells
‌
US Patent 7326569 Hybrid cells producing monoclonal anti-CD14 antibodies
‌
US Patent 7332157 Methods for human allografting
‌
US Patent 7332334 Hematopoietic stem cells treated by in vitro fucosylation and methods of use
‌
US Patent 7332592 Isolated recombinant bovine soluble CD14 polypeptide, rbosCD14
‌
US Patent 7344715 Method for treating multiple myeloma
‌
US Patent 7344881 Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
‌
US Patent 7361333 Prevention of diabetes through induction of immunological tolerance
‌
US Patent 7361334 Method of treatment of diabetes through induction of immunological tolerance
‌
US Patent 7361351 Method for sensitizing bovine mammary cells to respond to LPS
‌
US Patent 7364863 Monoclonal antibody W8B2 and method of use
‌
US Patent 7371380 Anti-Cark antibodies and uses therefor
‌
US Patent 7381563 Use of cytokines and mitogens to inhibit graft versus host disease
‌
US Patent 7381801 Chimerized GM-CSF antibodies
‌
US Patent 7384776 Expression vectors for increasing protein yield from a cell culture and methods of use thereof
‌
US Patent 7393684 Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodies
‌
US Patent 7438910 Therapeutic human anti-IL1-R1 monoclonal antibody
‌
US Patent 7442390 Method for enhancing engraftment of cells using mesenchymal progenitor cells
‌
US Patent 7442397 PEGylated fibrinogen-based biomatrix
‌
US Patent 7452981 Humanized anti-CD4 antibody with immunosuppressive properties
‌
US Patent 7456263 P53 binding T cell receptor molecules
‌
US Patent 7476724 Humanized anti-cmet antibodies
‌
US Patent 7943180 Method for stimulating a host immune system by administering an allogeneic cell material
‌
US Patent 7968304 Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin B peptides
‌
US Patent 7972801 Determining and reducing immunoresistance to a
‌
US Patent 7977095 Generation and isolation of antigen-specific T cells
‌
US Patent 7993660 Method of increasing immunological effect
‌
US Patent 8003101 Inflammatory mediator antagonists
‌
US Patent 8003385 In vitro germinal centers
‌
US Patent 8003387 In vitro germinal centers
‌
US Patent 8008028 Panel cell used for granulocyte antibody detection
‌
US Patent 8012476 Molecules with extended half-lives, compositions and uses thereof
‌
US Patent 8012750 T-cell activation device
Edits on 13 Dec, 2021
Golden AI profile picture
Golden AI
edited on 13 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 8012750 T-cell activation device
Golden AI profile picture
Golden AI
edited on 13 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 8012476 Molecules with extended half-lives, compositions and uses thereof
Edits on 8 Dec, 2021
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 8008028 Panel cell used for granulocyte antibody detection
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 8003387 In vitro germinal centers
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 8003385 In vitro germinal centers
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 8003101 Inflammatory mediator antagonists
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7993660 Method of increasing immunological effect
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7977095 Generation and isolation of antigen-specific T cells
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7972801 Determining and reducing immunoresistance to a
Golden AI profile picture
Golden AI
edited on 8 Dec, 2021
Edits on 7 Dec, 2021
Golden AI profile picture
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7943180 Method for stimulating a host immune system by administering an allogeneic cell material
Edits on 1 Dec, 2021
Golden AI profile picture
Golden AI
edited on 1 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7476724 Humanized anti-cmet antibodies
Golden AI profile picture
Golden AI
edited on 1 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7456263 P53 binding T cell receptor molecules
Golden AI profile picture
Golden AI
edited on 1 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7452981 Humanized anti-CD4 antibody with immunosuppressive properties
Golden AI profile picture
Golden AI
edited on 1 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7442397 PEGylated fibrinogen-based biomatrix
Golden AI profile picture
Golden AI
edited on 1 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7442390 Method for enhancing engraftment of cells using mesenchymal progenitor cells
Golden AI profile picture
Golden AI
edited on 1 Dec, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Patent primary examiner of
‌
US Patent 7438910 Therapeutic human anti-IL1-R1 monoclonal antibody
Edits on 30 Nov, 2021
Golden AI profile picture
Golden AI
edited on 30 Nov, 2021
Golden AI profile picture
Golden AI
edited on 30 Nov, 2021

Find more people like Michail Belyavskyi

Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.